SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Andrén Per E. Professor 1957 )
 

Search: WFRF:(Andrén Per E. Professor 1957 ) > Wide-Ranging Effect...

Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer's Disease Following Treatment with a Brain-Targeting Somatostatin Peptide

Rofo, Fadi (author)
Uppsala universitet,Institutionen för farmaci,Protein drug design
Sandbaumhüter, Friederike A. (author)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Medicinsk masspektrometri
Chourlia, Aikaterini (author)
Uppsala universitet,Institutionen för farmaci,Protein drug design
show more...
Metzendorf, Nicole G., 1979- (author)
Uppsala universitet,Institutionen för farmaci,Protein drug design
Morrison, Jamie I. (author)
Uppsala universitet,Institutionen för farmaci,Protein drug design
Syvänen, Stina (author)
Uppsala universitet,Geriatrik
Andrén, Per E., Professor, 1957- (author)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab,Medicinsk masspektrometri
Jansson, Erik T. (author)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Medicinsk masspektrometri
Hultqvist, Greta, 1980- (author)
Uppsala universitet,Institutionen för farmaci,Protein drug design
show less...
 (creator_code:org_t)
2021-06-25
2021
English.
In: ACS Chemical Neuroscience. - : American Chemical Society (ACS). - 1948-7193. ; 12:13, s. 2529-2541
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Alzheimer’s disease is the most common neurodegenerative disorder characterized by the pathological aggregation of amyloid-β (Aβ) peptide. A potential therapeutic intervention in Alzheimer’s disease is to enhance Aβ degradation by increasing the activity of Aβ-degrading enzymes, including neprilysin. The somatostatin (SST) peptide has been identified as an activator of neprilysin. Recently, we demonstrated the ability of a brain-penetrating SST peptide (SST-scFv8D3) to increase neprilysin activity and membrane-bound Aβ42 degradation in the hippocampus of mice overexpressing the Aβ-precursor protein with the Swedish mutation (APPswe). Using LC–MS, we further evaluated the anti-Alzheimer’s disease effects of SST-scFv8D3. Following a triple intravenous injection of SST-scFv8D3, the LC–MS analysis of the brain proteome revealed that the majority of downregulated proteins consisted of mitochondrial proteins regulating fatty acid oxidation, which are otherwise upregulated in APPswe mice compared to wild-type mice. Moreover, treatment with SST-scFv8D3 significantly increased hippocampal levels of synaptic proteins regulating cell membrane trafficking and neuronal development. Finally, hippocampal concentrations of growth-regulated α (KC/GRO) chemokine and degradation of neuropeptide-Y were elevated after SST-scFv8D3 treatment. In summary, our results demonstrate a multifaceted effect profile in regulating mitochondrial function and neurogenesis following treatment with SST-scFv8D3, further suggesting the development of Alzheimer’s disease therapies based on SST peptides.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Keyword

Alzheimer's disease
amyloid-beta
proteomics
somatostatin
SST-scFv8D3
LC-MS

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view